15:00 EDT Can-Fite BioPharma (CANF) trading resumes
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CANF:
- Can-Fite BioPharma announces $3.0M registered direct offering of ADSs
- Can-Fite BioPharma trading halted, news pending
- Can-Fite Projects $685M Revenue from Partnerships
- Can-Fite BioPharma announces completion of analysis of current partnerships
- Can-Fite BioPharma Reports 2024 Financial Results and Clinical Advances